山东大学耳鼻喉眼学报 ›› 2016, Vol. 30 ›› Issue (5): 110-114.doi: 10.6040/j.issn.1673-3770.0.2016.322

• 论著 • 上一篇    下一篇

RNAi沉默PDCD4基因对人喉癌Hep-2细胞增殖及β-catenin表达的影响

许元腾1,陈瑞庆2,林功标1,方秀玲1,俞舒娟1,梁晓华3,张榕1   

  1. 福建医科大学附属第一医院 1.耳鼻咽喉科;
    2.中心实验室;
    3.检验科, 福建 福州 350005
  • 收稿日期:2016-07-20 出版日期:2016-10-20 发布日期:2016-10-20
  • 通讯作者: 林功标. E-mail: lingongbiao@qq.com; 张榕. E-mail:zhang2012rong@sina.cn E-mail:xyt973@163.co
  • 作者简介:许元腾. E-mail:xyt973@163.co
  • 基金资助:
    福建省自然科学基金(2014j01311);福建省财政厅专项基金[闽财指(2015)1297号]

Effect of silencing PDCD4 gene on proliferation of Hep-2 cells and the expression of β-catenin by RNA interference technique.

XU Yuanteng1, CHEN Ruiqing2, LIN Gongbiao1, FANG Xiuling1, YU Shujuan1, LIANG Xiaohua3, ZHANG Rong   

  1. 1. Department of Otolaryngology;2. Central Laboratory;3. Clinical Laboratory, The First Affliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, China
  • Received:2016-07-20 Online:2016-10-20 Published:2016-10-20

摘要: 目的 应用RNAi技术下调人喉癌Hep-2细胞中PDCD4基因的表达,探讨其对Hep-2细胞增殖及β-catenin表达的影响。 方法 设计并合成针对PDCD4基因的shRNA质粒与阴性对照质粒,分别转染Hep-2细胞。实时定量RT-PCR和Western blotting检测转染前后阴性对照组与干扰组PDCD4、β-catenin基因mRNA和蛋白的表达。克隆形成实验观察Hep-2细胞增殖能力的变化。 结果 与对照组相比,PDCD4干扰组的Hep-2细胞克隆形成率显著升高(P=0.01),PDCD4干扰组PDCD4mRNA和蛋白均显著减低(P<0.01)、β-catenin mRNA和蛋白均较对照组显著增加(P<0.01)。 结论 成功应用RNAi技术下调人喉癌Hep-2细胞中PDCD4基因的表达,Hep-2细胞克隆形成能力增强,β-catenin mRNA和蛋白表达显著升高。

关键词: RNA干扰, 喉癌, Hep-2细胞, β-catenin, 细胞增殖, PDCD4基因

Abstract: Objective To study the effect of silencing PDCD4 gene on proliferation of Hep-2 cells and the expression of β-catenin by RNA interference technique. Methods Specific shRNA plasmid and negative control plasmid of PDCD4 gene were designed and synthesized. Hep-2 cells were transfected with shRNA plasmid and negative control plasmid. Real-time RT-PCR and Western blotting analysis were performed to determine the expressions of PDCD4 and β-catenin mRNA and protein after transfection, respectively. The proliferation of Hep-2 cells was observed by colony-forming assay. Results Compared to the control group, the colony formation rate of Hep-2 cells was significantly increased in the shRNNA plasmid group(P=0.01); the expressions of PDCD4 mRNA and protein were significantly reduced(P<0.01);the expressions of β-catenin mRNA and protein were significantly increased(P<0.01). Conclusion RNA interference technique can effectively silence PDCD4 gene expression of Hep-2 cells,enhance the colony forming ability of Hep-2 and increase the expressions of β-catenin mRNA and protein.

Key words: Hep-2 cell, PDCD4 gene, β-catenin, Cell proliferation, Laryngeal cancer, RNA interference

中图分类号: 

  • R739.65
[1] Ferlay J, Shin H R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917.
[2] Shangina O, Brennan P, Szeszenia-Dabrowska N, et al. Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe[J]. Am J Epidemiol, 2006, 164(4): 367-375.
[3] Gao X, Fisher S G, Mohideen N, et al. Second primary cancers in patients with laryngeal cancer: a population-based study[J]. Int J Radiat Oncol Biol Phys, 2003, 56(2): 427-435.
[4] Marioni G, Marchese-Ragona R, Cartei G, et al. Current opinion in diagnosis and treatment of laryngeal carcinoma[J]. Cancer Treat Rev, 2006, 32(7): 504-515.
[5] Wang Q, Zhu J, Zhang Y, et al. Down-regulation of programmed cell death 4 leads to epithelial to mesenchymal transition and promotes metastasis in mice[J]. Eur J Cancer, 2013, 49(7): 1761-70.
[6] 冯国飞, 李培华, 尤慧华, 等. 喉癌组织中程序性细胞死亡因子4的表达及临床意义[J]. 临床耳鼻咽喉头颈外科杂志, 2011, 25(1): 16-19. FENG Guofei, LI Peihua, YOU Huihua, et al. The expression and clinical pathological significance of PDCD in laryngocarcinoma[J]. J Clin Otorhinolaryngol Head Neck Surgery, 2011, 25(1): 16-19.
[7] Shibahara K, Asano M, Ishida Y, et al. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death[J]. Gene, 1995, 166(2): 297-301.
[8] Wedeken L, Ohnheiser J, Hirschi B, et al. Association of Tumor Suppressor Protein Pdcd4 With Ribosomes Is Mediated by Protein-Protein and Protein-RNA Interactions[J]. Genes Cancer, 2010, 1(3): 293-301.
[9] Wen Y H, Shi X, Chiriboga L, et al. Alterations in the expression of PDCD4 in ductal carcinoma of the breast[J]. Oncol Rep, 2007, 18(6): 1387-1393.
[10] Zhang H, Ozaki I, Mizuta T, et al. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma[J]. Oncogene, 2006, 25(45): 6101-6112.
[11] Chen Y, Kn(¨overo)sel T, Kristiansen G, et al. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis[J]. J Pathol, 2003, 200(5): 640-646.
[12] 纪旭, 李虹, 符静, 等. PDCD4在喉癌中的表达及意义[J]. 解剖科学进展, 2014, 20(3): 273-275. JI Xu, LI Hong, FU Jing, et al. Expression and significance of PDCD4 in human laryngeal squamous cell carcinoma[J]. Prog Anat Sci, 2014, 20(3):273-275.
[13] Mudduluru G, Medved F, Grobholz R, et al. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer[J]. Cancer, 2007, 110(8): 1697-1707.
[14] Wang Q, Sun Z, Yang H S. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells[J]. Oncogene, 2008, 27(11): 1527-1535.
[15] 于锋, 黄鑫, 林颖, 等. siRNA下调β-catenin基因对喉癌Hep-2细胞增殖、凋亡和侵袭的影响[J]. 中国耳鼻咽喉头颈外科,2015,22(7): 329-333. YU Feng, HUANG Xin, LIN Ying, et al. Effect of siRNA downregulation of β-catenin on proliferation, apoptosis and invasion of laryngeal carcinoma Hep-2 cells[J]. Chin Arch Otolaryngol Head Neck Surgery, 2015,22(7): 329-333.
[16] Macdonald B T, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases[J]. Developmental Cell, 2009, 17(1):9-26.
[17] Wang Q, Sun Z X, Allgayer H, et al. Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells[J]. Oncogene, 2010, 29(1):128-138.
[18] Pietruszewska W, Kobos J, Gryczyński M. [Expression of beta-catenin protein in laryngeal squamous-cell carcinoma].[J]. Otolaryngologia Polska Polish Otolaryngol, 2004, 58(5):949-956.
[1] 叶树凤,张旭,苏凯,李贺杰,滕博. 喉癌喉部分切除术术后喉囊肿一例及文献复习[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 117-118.
[2] 李国彬,张占成,王新颜. 上调miR-200b对人喉癌Hep-2细胞增殖、迁移和侵袭能力的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 53-57.
[3] 赵小燕,吴彩琴,任晓勇,王正辉. 白花蛇舌草多糖提取物诱导Hep-2细胞凋亡与抑制侵袭机制[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 84-87.
[4] 包伟晶,宁佳羽,朱忠寿,魏日富,林昶. CO2激光切除累及前联合的早期声门癌26例[J]. 山东大学耳鼻喉眼学报, 2016, 30(5): 101-105.
[5] 马玲国,郑朝攀,周敬淳,张博,龚桃根,张云静. CO2激光治疗声门型喉癌远期疗效分析[J]. 山东大学耳鼻喉眼学报, 2016, 30(5): 98-100.
[6] 李晓明,宋琦,李红霞,陶振峰,申宇鹏,肖淑芬. 胸大肌肌皮瓣在侵犯下咽晚期头颈鳞癌手术切除术后缺损修复中的应用[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 4-9.
[7] 李泽文,郭俊宇,周洁,严福波,杨志敏,丁珠华. 胃食管反流病与喉癌关系的Meta分析[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 40-46.
[8] 晋舒. 全喉切除术后气管感染对喉癌患者肺功能及肿瘤复发率的影响[J]. 山东大学耳鼻喉眼学报, 2016, 30(3): 37-39.
[9] 李盈盈, 周涵, 张伟强, 董伟达. 沉默HIF-1α基因对鼻黏膜上皮细胞生长因子表达的影响[J]. 山东大学耳鼻喉眼学报, 2015, 29(5): 38-42.
[10] 严羽, 朱江. 早期喉癌及喉癌前病变诊断的研究进展[J]. 山东大学耳鼻喉眼学报, 2015, 29(4): 80-85.
[11] 陈小玲, 费兵, 李贤斌, 吴昊. 靶向人喉癌HEP2细胞Trop2基因的siRNA构建及鉴定[J]. 山东大学耳鼻喉眼学报, 2015, 29(3): 51-53.
[12] 林丹,董伟达,陆美萍,邢光前,董佳迪,张伟强. MicroRNA-146a前体区基因多态性与江苏地区汉族人群喉癌遗传易感性的关联性分析[J]. 山东大学耳鼻喉眼学报, 2014, 28(2): 46-50.
[13] 赵永强1,冯慧伟1,于克娜1,石梅2,范献良1 . 塞来昔布诱导喉癌Hep-2细胞凋亡的实验研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(2): 41-45.
[14] 郑立友. 中西医结合治疗喉癌下咽癌手术并发咽瘘10例[J]. 山东大学耳鼻喉眼学报, 2012, 26(6): 31-33.
[15] 贾传亮,王丽综述,陈秀梅,宋西成审校. T1b声门型喉癌的治疗进展[J]. 山东大学耳鼻喉眼学报, 2012, 26(6): 83-83.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!